PT3030519T - Compostos de benzoxaborol tricíclicos e utilizações dos mesmos - Google Patents

Compostos de benzoxaborol tricíclicos e utilizações dos mesmos

Info

Publication number: PT3030519T
Authority: PT; Portugal
Prior art keywords: benzoxaborole compounds; tricyclic benzoxaborole; tricyclic; compounds; benzoxaborole
Prior art date: 2013-08-09

Application number

PT148342926T

Other languages

English (en)

Original Assignee

Anacor Pharmaceuticals Inc

Glaxosmithkline Ip No 2 Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-08-09

Filing date

2014-08-08

Publication date

2022-01-27

2014-08-08 Application filed by Anacor Pharmaceuticals Inc, Glaxosmithkline Ip No 2 Ltd filed Critical Anacor Pharmaceuticals Inc

2022-01-27 Publication of PT3030519T publication Critical patent/PT3030519T/pt

Links

GDMJXXLVTYSBBE-UHFFFAOYSA-N 1,2-benzoxaborole Chemical class C1=CC=C2OB=CC2=C1 GDMJXXLVTYSBBE-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Neurology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

PT148342926T 2013-08-09 2014-08-08 Compostos de benzoxaborol tricíclicos e utilizações dos mesmos PT3030519T (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201361864496P	2013-08-09	2013-08-09
US201361918976P	2013-12-20	2013-12-20

Publications (1)

Publication Number	Publication Date
PT3030519T true PT3030519T (pt)	2022-01-27

Family

ID=52462052

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT148342926T PT3030519T (pt)	2013-08-09	2014-08-08	Compostos de benzoxaborol tricíclicos e utilizações dos mesmos

Country Status (35)

Country	Link
US (5)	US20160251380A1 (pt)
EP (2)	EP3030519B1 (pt)
JP (2)	JP6499175B2 (pt)
KR (1)	KR102093783B1 (pt)
CN (2)	CN110003253B (pt)
AP (1)	AP2016009046A0 (pt)
AU (2)	AU2014305792C1 (pt)
BR (1)	BR112016002651B1 (pt)
CA (1)	CA2919888C (pt)
CL (1)	CL2016000313A1 (pt)
CR (1)	CR20160064A (pt)
CY (1)	CY1125030T1 (pt)
DK (1)	DK3030519T3 (pt)
DO (1)	DOP2016000045A (pt)
EA (1)	EA032844B1 (pt)
ES (1)	ES2905413T3 (pt)
HK (1)	HK1219939A1 (pt)
HR (1)	HRP20220384T1 (pt)
HU (1)	HUE057365T2 (pt)
IL (1)	IL243874B (pt)
LT (1)	LT3030519T (pt)
MX (1)	MX2016001732A (pt)
MY (1)	MY175823A (pt)
NZ (1)	NZ716350A (pt)
PE (1)	PE20160752A1 (pt)
PH (1)	PH12016500234A1 (pt)
PL (1)	PL3030519T3 (pt)
PT (1)	PT3030519T (pt)
RS (1)	RS62887B1 (pt)
SA (1)	SA516370551B1 (pt)
SG (2)	SG11201600787PA (pt)
SI (1)	SI3030519T1 (pt)
UA (1)	UA116908C2 (pt)
WO (1)	WO2015021396A2 (pt)
ZA (1)	ZA201600792B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR094961A1 (es) *	2013-03-15	2015-09-09	Lilly Co Eli	1-hidroxi-benzooxaboroles como agentes antiparasitarios
KR101636431B1 (ko)	2013-07-30	2016-07-05	동아에스티 주식회사	트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
ES2905413T3 (es) *	2013-08-09	2022-04-08	Glaxosmithkline Ip No 2 Ltd	Compuestos tricíclicos de benzoxaborol y usos de los mismos
ES2732465T3 (es)	2014-07-01	2019-11-22	Daiichi Sankyo Co Ltd	Benzoxaboroles tricíclicos como agentes antibacterianos
MA41495A (fr)	2015-02-12	2017-12-19	Anacor Pharmaceuticals Inc	Composés benzoxaborole et leurs utilisations
EP3455227A1 (en)	2016-05-12	2019-03-20	Anacor Pharmaceuticals, Inc	Oxaborole esters and uses thereof
CN109387594B (zh) *	2017-08-08	2021-01-19	武汉武药科技有限公司	一种分离和分析贝达喹啉光学异构体的方法
PL3737685T3 (pl) *	2018-01-09	2023-10-02	Halcyon Labs Private Limited	Sposób wytwarzania kryzaborolu i jego związków pośrednich
WO2021257466A1 (en) *	2020-06-15	2021-12-23	The Global Alliance For Tb Drug Development, Inc.	Combination antibacterial composition and method for antibacterial therapy
CN111606850B (zh) *	2020-07-07	2023-07-25	安徽贝克生物制药有限公司	贝达喹啉及其中间体的制备方法
US11793808B2 (en)	2021-02-22	2023-10-24	Mannkind Corp.	Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
CA3239096A1 (en) *	2022-06-23	2023-12-28	Shanghai Micurx Pharmaceutical Co., Ltd.	Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same
CA3239097A1 (en) *	2022-06-23	2023-12-28	Shanghai Micurx Pharmaceutical Co., Ltd.	Prodrugs of boron compounds and their use in treating bacterial infections

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4967997A (en)	1996-12-02	1998-06-29	Chisso Corporation	Optically active nitro alcohol derivatives, optically active amino alcohol derivates, and process for preparing the same
US7446236B2 (en)	2002-12-02	2008-11-04	Solvias Ag	Catalytic hydrogenation of carbon-heteroatom double bonds
CA2597982C (en) *	2005-02-16	2014-07-08	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
US7767657B2 (en)	2005-02-16	2010-08-03	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
US7919422B2 (en)	2005-03-08	2011-04-05	Agency For Science, Technology And Research	Chiral bisoxazoline catalysts
CN101505603A (zh) *	2005-12-30	2009-08-12	安纳考尔医药公司	含硼的小分子
KR100848491B1 (ko)	2007-01-16	2008-07-28	영진약품공업주식회사	베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar)	2007-06-20	2019-10-20	Anacor Pharmaceuticals Inc	جزيئات صغيرة تحتوي على البورون
EP2378886A4 (en)	2008-12-17	2012-08-29	Anacor Pharmaceuticals Inc	(S) -3-Aminomethyl-7- (3-hydroxypropoxy) -3H-benzo [c] [1,2] oxaborole-1-OL-POLYMORPHS
US9243003B2 (en) *	2010-04-07	2016-01-26	Glaxosmithkline Llc	Process for preparing benzoxaboroles
JP5952280B2 (ja) *	2010-09-07	2016-07-13	アナコールファーマシューティカルズ，インコーポレーテッド	細菌感染治療用のベンゾオキサボロール誘導体
EP2793901A1 (en) *	2011-12-22	2014-10-29	Micurx Pharmaceuticals, Inc.	Tricyclic boron compounds for antimicrobial therapy
KR101636431B1 (ko)	2013-07-30	2016-07-05	동아에스티 주식회사	트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
ES2905413T3 (es)	2013-08-09	2022-04-08	Glaxosmithkline Ip No 2 Ltd	Compuestos tricíclicos de benzoxaborol y usos de los mismos
MA41495A (fr) *	2015-02-12	2017-12-19	Anacor Pharmaceuticals Inc	Composés benzoxaborole et leurs utilisations

2014
- 2014-08-08 ES ES14834292T patent/ES2905413T3/es active Active
- 2014-08-08 AP AP2016009046A patent/AP2016009046A0/en unknown
- 2014-08-08 BR BR112016002651-9A patent/BR112016002651B1/pt active IP Right Grant
- 2014-08-08 PT PT148342926T patent/PT3030519T/pt unknown
- 2014-08-08 LT LTEPPCT/US2014/050370T patent/LT3030519T/lt unknown
- 2014-08-08 WO PCT/US2014/050370 patent/WO2015021396A2/en active Application Filing
- 2014-08-08 UA UAA201600796A patent/UA116908C2/uk unknown
- 2014-08-08 CA CA2919888A patent/CA2919888C/en active Active
- 2014-08-08 AU AU2014305792A patent/AU2014305792C1/en active Active
- 2014-08-08 MY MYPI2016700458A patent/MY175823A/en unknown
- 2014-08-08 CN CN201811396796.1A patent/CN110003253B/zh active Active
- 2014-08-08 EP EP14834292.6A patent/EP3030519B1/en active Active
- 2014-08-08 PE PE2016000234A patent/PE20160752A1/es unknown
- 2014-08-08 NZ NZ716350A patent/NZ716350A/en unknown
- 2014-08-08 RS RS20220108A patent/RS62887B1/sr unknown
- 2014-08-08 HR HRP20220384TT patent/HRP20220384T1/hr unknown
- 2014-08-08 PL PL14834292T patent/PL3030519T3/pl unknown
- 2014-08-08 DK DK14834292.6T patent/DK3030519T3/da active
- 2014-08-08 SI SI201431939T patent/SI3030519T1/sl unknown
- 2014-08-08 HU HUE14834292A patent/HUE057365T2/hu unknown
- 2014-08-08 JP JP2016533471A patent/JP6499175B2/ja active Active
- 2014-08-08 CN CN201480049562.3A patent/CN105492388B/zh active Active
- 2014-08-08 SG SG11201600787PA patent/SG11201600787PA/en unknown
- 2014-08-08 EA EA201690135A patent/EA032844B1/ru unknown
- 2014-08-08 MX MX2016001732A patent/MX2016001732A/es active IP Right Grant
- 2014-08-08 EP EP21214787.0A patent/EP4029870A1/en not_active Withdrawn
- 2014-08-08 KR KR1020167006314A patent/KR102093783B1/ko active IP Right Grant
- 2014-08-08 SG SG10201914073PA patent/SG10201914073PA/en unknown
- 2014-08-08 US US14/387,384 patent/US20160251380A1/en not_active Abandoned
2016
- 2016-01-28 IL IL243874A patent/IL243874B/en active IP Right Grant
- 2016-02-03 PH PH12016500234A patent/PH12016500234A1/en unknown
- 2016-02-04 ZA ZA2016/00792A patent/ZA201600792B/en unknown
- 2016-02-07 SA SA516370551A patent/SA516370551B1/ar unknown
- 2016-02-08 CL CL2016000313A patent/CL2016000313A1/es unknown
- 2016-02-09 CR CR20160064A patent/CR20160064A/es unknown
- 2016-02-09 DO DO2016000045A patent/DOP2016000045A/es unknown
- 2016-07-08 HK HK16107991.6A patent/HK1219939A1/zh unknown
2017
- 2017-08-03 AU AU2017210567A patent/AU2017210567B2/en active Active
- 2017-10-24 US US15/792,251 patent/US10308668B2/en active Active
2019
- 2019-03-14 JP JP2019046582A patent/JP6764970B2/ja active Active
- 2019-04-16 US US16/385,547 patent/US10526352B2/en active Active
- 2019-11-26 US US16/695,253 patent/US10858376B2/en active Active
2020
- 2020-11-04 US US17/089,058 patent/US20210053999A1/en not_active Abandoned
2022
- 2022-03-01 CY CY20221100169T patent/CY1125030T1/el unknown

Also Published As

Publication number	Publication date
WO2015021396A3 (en)	2015-10-29
LT3030519T (lt)	2022-04-11
CR20160064A (es)	2016-06-01
NZ716350A (en)	2022-12-23
JP2019123727A (ja)	2019-07-25
KR20160038901A (ko)	2016-04-07
US20190241586A1 (en)	2019-08-08
HRP20220384T1 (hr)	2022-07-22
CA2919888A1 (en)	2015-02-12
BR112016002651B1 (pt)	2022-11-29
PE20160752A1 (es)	2016-08-17
US10526352B2 (en)	2020-01-07
WO2015021396A2 (en)	2015-02-12
AP2016009046A0 (en)	2016-02-29
PH12016500234B1 (en)	2016-05-16
CN110003253B (zh)	2022-03-18
RS62887B1 (sr)	2022-03-31
SG10201914073PA (en)	2020-03-30
MX2016001732A (es)	2016-05-18
CA2919888C (en)	2022-10-18
IL243874B (en)	2018-11-29
SG11201600787PA (en)	2016-03-30
PL3030519T3 (pl)	2022-05-23
US20160251380A1 (en)	2016-09-01
JP2016527321A (ja)	2016-09-08
CN105492388B (zh)	2018-12-21
US10858376B2 (en)	2020-12-08
SA516370551B1 (ar)	2017-10-31
ES2905413T3 (es)	2022-04-08
MY175823A (en)	2020-07-10
PH12016500234A1 (en)	2016-05-16
DOP2016000045A (es)	2016-04-29
ZA201600792B (en)	2022-05-25
AU2017210567B2 (en)	2019-08-01
AU2014305792C1 (en)	2018-07-05
CN105492388A (zh)	2016-04-13
CN110003253A (zh)	2019-07-12
HK1219939A1 (zh)	2017-04-21
US10308668B2 (en)	2019-06-04
US20180044355A1 (en)	2018-02-15
EP4029870A1 (en)	2022-07-20
SI3030519T1 (sl)	2022-04-29
EA201690135A1 (ru)	2016-07-29
EP3030519B1 (en)	2022-01-05
AU2017210567A1 (en)	2017-08-24
EA032844B1 (ru)	2019-07-31
IL243874A0 (en)	2016-04-21
UA116908C2 (uk)	2018-05-25
US20210053999A1 (en)	2021-02-25
JP6764970B2 (ja)	2020-10-07
BR112016002651A2 (pt)	2017-08-01
AU2014305792B2 (en)	2017-05-04
EP3030519A2 (en)	2016-06-15
CY1125030T1 (el)	2023-03-24
DK3030519T3 (da)	2022-01-31
CL2016000313A1 (es)	2016-09-23
EP3030519A4 (en)	2017-03-08
HUE057365T2 (hu)	2022-05-28
WO2015021396A9 (en)	2016-02-11
AU2014305792A1 (en)	2016-03-10
US20200095266A1 (en)	2020-03-26
JP6499175B2 (ja)	2019-04-10
KR102093783B1 (ko)	2020-03-26

Publication	Publication Date	Title
IL274355B (en)	2021-02-28	Aza-pyridone compounds and their uses
HK1248138A1 (zh)	2018-10-12	咪唑並吡啶化合物及其用途
HK1226056A1 (zh)	2017-09-22	吡唑並化合物及其用途
HK1219939A1 (zh)	2017-04-21	三環苯並氧雜硼雜環戊烯化合物及其用途
EP2963027A4 (en)	2016-07-20	TRICYCLIC CONNECTION AND USE THEREOF
HUE054178T2 (hu)	2021-08-30	Metil/fluor-piridinil-metoxi-szubsztituált piridinon-piridinil-vegyületek és fluor-pirimidinil-metoxi-szubsztituált piridinon-piridinil-vegyületek
GB201323008D0 (en)	2014-02-12	Compounds and uses thereof
HK1205545A1 (en)	2015-12-18	Padlock
GB201321693D0 (en)	2014-01-22	Composition and uses thereof
GB201312318D0 (en)	2013-08-21	Novel methods and compounds
GB201300707D0 (en)	2013-02-27	Compounds and processes
GB201307233D0 (en)	2013-05-29	Compounds and uses thereof
GB201309180D0 (en)	2013-07-03	Compounds and Their Uses
HK1223307A1 (zh)	2017-07-28	新型化合物和其用途
GB201314610D0 (en)	2013-10-02	Compounds and their uses
ZA201601880B (en)	2017-09-27	Hetero-transglycosylase and uses thereof
GB201306248D0 (en)	2013-05-22	Compounds and their uses
GB201320161D0 (en)	2014-01-01	Compounds and their uses
GB201323005D0 (en)	2014-02-12	Compounds and uses thereof
GB201307202D0 (en)	2013-05-29	New compounds and uses
GB201307201D0 (en)	2013-05-29	New compounds and uses
GB201301734D0 (en)	2013-03-20	New compounds and uses
GB201309248D0 (en)	2013-07-03	Compounds and combinations
GB201313605D0 (en)	2013-09-11	Novel compounds and their use
GB201301022D0 (en)	2013-03-06	Composition and uses thereof